(Q43037932)

English

Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment

scientific article published in October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Activating NK cell receptor expression/function (NKp30, NKp46, DNAM-1) during chronic viraemic HCV infection is associated with the outcome of combined treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

6

object named as

Ivan Hirsch

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Federica Bozzano

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Antonino Picciotto

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Paola Costa

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Francesco Marras

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Valentina Fazio

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Daniel Olive

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Lorenzo Moretta

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Andrea De Maria

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

1 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

European Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

41

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

2905-2914

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Analysis of successful immune responses in persons infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Viral modulation of NK cell immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Imprint of human cytomegalovirus infection on the NK cell receptor repertoire

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Natural killer cell function is intact after direct exposure to infectious hepatitis C virions.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Activation of natural killer cells during acute infection with hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Defective dendritic cell function in HIV-infected patients receiving effective highly active antiretroviral therapy: neutralization of IL-10 production and depletion of CD4+CD25+ T cells restore high levels of HIV-specific CD4+ T cell responses indu

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Natural killer cells and dendritic cells: rendezvous in abused tissues

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Early liaisons between cells of the innate immune system in inflamed peripheral tissues.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

NK cells at the interface between innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Effect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus Infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

CD107a as a functional marker for the identification of natural killer cell activity.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Differential NKp30 inducibility in chimpanzee NK cells and conserved NK cell phenotype and function in long-term HIV-1-infected animals.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

Interferon signaling and treatment outcome in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

21 January 2018

The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjects

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

The dialogue between human natural killer cells and dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased susceptibility to apoptosis of CD56dimCD16+ NK cells induces the enrichment of IFN-gamma-producing CD56bright cells in tuberculous pleurisy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201041361

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/EJI.201041361

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43037932&oldid=1978292777"